tilomisole has been researched along with Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hadden, JW | 1 |
Dillman, JB; Dillman, RO; Maguire, R; Ryan, KP; Shawler, DL | 1 |
2 other study(ies) available for tilomisole and Neoplasms
Article | Year |
---|---|
Chemically defined immunotherapeutic agents.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; Benzimidazoles; Cimetidine; Ditiocarb; Humans; Hypoxanthines; Inosine Pranobex; Leucine; Levamisole; Mice; Neoplasms; Pyran Copolymer; Tuftsin | 1983 |
WY 18,251 (Tilomisole), an analog of levamisole: tolerability, and immune modulating effects in cancer patients.
Topics: Adjuvants, Immunologic; Adult; Aged; Benzimidazoles; Drug Evaluation; Drug Tolerance; Female; Humans; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Middle Aged; Neoplasms; T-Lymphocytes | 1992 |